supplier
BioCryst Ireland Limited
BioCryst Ireland Limited has won 5 UK public sector awards from 2 buyers since 2022. The typical award is worth £74,500,000.
as a supplier
5 recorded awards from 2 buyers , between 19 Jun 2022 and 24 Mar 2025.
“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.
sells to
| buyer | awards |
|---|---|
| NHS England | 4 |
| Belfast Health and Social Care Trust | 1 |
common questions about BioCryst Ireland Limited
How many public sector contracts has BioCryst Ireland Limited won?
- BioCryst Ireland Limited has won 5 UK public sector contracts from 2 public bodies since 2022.
Which public bodies buy from BioCryst Ireland Limited?
- BioCryst Ireland Limited has won the most contracts from NHS England and Belfast Health and Social Care Trust.
How large are BioCryst Ireland Limited's contracts?
- The median published value of a contract won by BioCryst Ireland Limited is £74,500,000. Framework ceilings are excluded, because they state a spending limit shared across many suppliers rather than a value one supplier received.
Which BioCryst Ireland Limited contracts are expiring soon?
- 1 contract involving BioCryst Ireland Limited has an end date in the next 12 months, the earliest on 31 Dec 2026.
contracts expiring in the next 12 months
Contract end dates as published on the original notice. An end date is not a commitment to re-tender — a contract may be extended, varied or allowed to lapse — but it is the earliest public signal that work may come back to market.
| contract | counterparty | value | ends |
|---|---|---|---|
| NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema | NHS ENGLAND | · | 31 Dec 2026 |
contracts won
| contract | buyer | value | awarded |
|---|---|---|---|
| NHS Framework Agreement for Branded Medicines - Proprietary Category Tender shared | NHS England | £1,241,520,444 | 24 Mar 2025 |
| Hereditary Angioedema shared | NHS England | £74,500,000 | 19 Jun 2022 |
| NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025 shared | NHS England | · | 22 Apr 2025 |
| BEROTRALSTAT 150 mg Tablets 28 Tablet Box | BELFAST HEALTH AND SOCIAL CARE TRUST | · | 19 Feb 2024 |
| NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema shared | NHS ENGLAND | · | 5 Jul 2022 |
every contract won by BioCryst Ireland Limited →
where these figures come from
Every figure on this page is derived from notices published by Contracts Finder, Find a Tender, Public Contracts Scotland and Sell2Wales, under the Open Government Licence v3.0. The corpus runs from 17 Dec 2014 to 13 Sept 2026 and is refreshed from the publishers' own APIs through the working day.
Records are combined into one organisation on identifiers where publishers provide them — a Companies House number, a GB-PPON supplier id — and on exact normalised name and address where they do not. Never on address alone: one shared-service postcode carries 244 unrelated organisations.
Counts are of contracting processes, not published notices: a tender and its award notice are one contract, and are counted once. Values are medians, never totals, and exclude framework ceilings — a ceiling states a spending limit shared across every supplier on the framework, so adding them together produces a number no one ever spent. sources and coverage · how matching works
Contains public sector information licensed under the Open Government Licence v3.0.